Stefan Schulte

Person

Marburg, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Truncated von Willebrand Factor polypeptides for treating hemophilia
- Patent number 11,814,421
- Issue date Nov 14, 2023
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand Factor
- Patent number 11,564,976
- Issue date Jan 31, 2023
- CSL Behring Lengnau AG
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for improving the stability of purified Factor VIII after re...
- Patent number 11,510,968
- Issue date Nov 29, 2022
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified von Willebrand factor having improved half-life
- Patent number 11,155,601
- Issue date Oct 26, 2021
- CSL BEHRING LENGNAU AG
- Michael Moses
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for preparing modified von Willebrand factor
- Patent number 10,905,747
- Issue date Feb 2, 2021
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified Factor VIII after re...
- Patent number 10,881,717
- Issue date Jan 5, 2021
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparing modified von Willebrand factor
- Patent number 10,772,936
- Issue date Sep 15, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- G01 - MEASURING TESTING
Information Patent Grant
Truncated von Willebrand factor polypeptides for treating hemophilia
- Patent number 10,688,157
- Issue date Jun 23, 2020
- CSL BEHRING LENGNAU AG
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified factor VIII after re...
- Patent number 10,537,616
- Issue date Jan 21, 2020
- CSL Limited
- Carsten Horn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sugar compositions for treating hemophilia A and/or Von Willebrand...
- Patent number 10,232,015
- Issue date Mar 19, 2019
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor XII inhibitors for the administration with medical procedure...
- Patent number 9,987,328
- Issue date Jun 5, 2018
- CSL Behring GmbH
- Stefan Zeitler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified factor VIII after re...
- Patent number 9,956,269
- Issue date May 1, 2018
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent complex of von Willebrand Factor and factor VIII, composit...
- Patent number 9,878,017
- Issue date Jan 30, 2018
- CSL Ltd.
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sugar compositions for treating hemophilia A and/or von Willebrand...
- Patent number 9,707,269
- Issue date Jul 18, 2017
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Von willebrand factor variants having improved factor VIII binding...
- Patent number 9,458,223
- Issue date Oct 4, 2016
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of C1-inhibitor for the treatment of secondary edema of the cen...
- Patent number 9,452,203
- Issue date Sep 27, 2016
- CSL Behring GmbH
- Christoph Kleinschnitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving the stability of purified factor VIII after re...
- Patent number 9,394,353
- Issue date Jul 19, 2016
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor XII inhibitors for the administration with medical procedure...
- Patent number 9,352,016
- Issue date May 31, 2016
- CSL Behring GmbH
- Stefan Zeitler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coagulation factor X polypeptides with modified activation properties
- Patent number 9,347,051
- Issue date May 24, 2016
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII, von Willebrand factor or complexes thereof with prolon...
- Patent number 9,290,561
- Issue date Mar 22, 2016
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coagulation factor X polypeptides with modified activation properties
- Patent number 9,249,404
- Issue date Feb 2, 2016
- CSL Behring GmbH
- Stefan Schulte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified vitamin K dependent polypeptides
- Patent number 8,828,939
- Issue date Sep 9, 2014
- CSL Behring GmbH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified coagulation factor VIIa with extended half-life
- Patent number 8,765,915
- Issue date Jul 1, 2014
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified coagulation factors with prolonged in vivo half-life
- Patent number 8,754,194
- Issue date Jun 17, 2014
- CSL Behring GmbH
- Stefan Schulte
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII, von willebrand factor or complexes thereof with prolon...
- Patent number 8,575,104
- Issue date Nov 5, 2013
- CSL Behring GmbH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Therapeutic application of Kazal-type serine protease inhibitors
- Patent number 8,283,319
- Issue date Oct 9, 2012
- CSL Behring GmbH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Proteolytically cleavable fusion proteins with high molar specific...
- Patent number 7,939,632
- Issue date May 10, 2011
- CSL Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Concentrate of a factor VIII:C-containing von Willebrand factor and...
- Patent number 7,625,866
- Issue date Dec 1, 2009
- CSL Behring GmbH
- Gerhardt Kumpe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibrinogen purification
- Patent number 7,550,567
- Issue date Jun 23, 2009
- CSL Behring GmbH
- Hubert Metzner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Storage-stable, liquid fibrinogen formulation
- Patent number 7,045,601
- Issue date May 16, 2006
- ZLB Behring GmbH
- Hubert Metzner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20210308229
- Publication date Oct 7, 2021
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20210121535
- Publication date Apr 29, 2021
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20200368327
- Publication date Nov 26, 2020
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATI...
- Publication number 20200338123
- Publication date Oct 29, 2020
- CSL BEHRING GMBH
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20200268854
- Publication date Aug 27, 2020
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20200095567
- Publication date Mar 26, 2020
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20190263890
- Publication date Aug 29, 2019
- CSL BEHRING LENGNAU AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20190038722
- Publication date Feb 7, 2019
- CSL Limited
- Carsten Horn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA
- Publication number 20180161402
- Publication date Jun 14, 2018
- CSL Behring Recombinant Facility AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
- Publication number 20180153968
- Publication date Jun 7, 2018
- CSL Behring Recombinant Facility AG
- Stefan SCHULTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20180119128
- Publication date May 3, 2018
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSIT...
- Publication number 20180092966
- Publication date Apr 5, 2018
- CSL Limited
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED VON WILLEBRAND FACTOR HAVING IMPROVED HALF-LIFE
- Publication number 20180051067
- Publication date Feb 22, 2018
- CSL Behring Recombinant Facility AG
- Michael MOSES
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR IMPROVING THE HALF-LIFE OF VON WILLEBRAND FACTOR
- Publication number 20180043012
- Publication date Feb 15, 2018
- CSL Behring Recombinant Facility AG
- Michael MOSES
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sugar Compositions for Treating Hemophilia A and/or Von Willebrand...
- Publication number 20170274045
- Publication date Sep 28, 2017
- CSL BEHRING GMBH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
- Publication number 20170080061
- Publication date Mar 23, 2017
- CSL BEHRING GMBH
- Thomas WEIMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...
- Publication number 20160367641
- Publication date Dec 22, 2016
- CSL Limited
- Carsten HORN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR XII INHIBITORS FOR THE ADMINISTRATION WITH MEDICAL PROCEDURE...
- Publication number 20160279195
- Publication date Sep 29, 2016
- CSL BEHRING GMBH
- Stefan ZEITLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPLEX
- Publication number 20160200794
- Publication date Jul 14, 2016
- CSL Limited
- Hubert METZNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...
- Publication number 20160010074
- Publication date Jan 14, 2016
- CSL BEHRING GMBH
- Hubert METZNER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATI...
- Publication number 20150150911
- Publication date Jun 4, 2015
- CSL BEHRING GMBH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Sugar Compositions for Treating Hemophilia A and/or Von Willebrand...
- Publication number 20150087592
- Publication date Mar 26, 2015
- CSL BEHRING GMBH
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF C1-INHIBITOR FOR THE TREATMENT OF SECONDARY EDEMA OF THE CEN...
- Publication number 20140371425
- Publication date Dec 18, 2014
- CSL BEHRING GMBH
- Christoph Kleinschnitz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Von Willebrand Factor Variants Having Improved Factor VIII Binding...
- Publication number 20140357564
- Publication date Dec 4, 2014
- Stefan Schulte
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE
- Publication number 20140356346
- Publication date Dec 4, 2014
- CSL BEHRING GMBH
- Thomas WEIMER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE
- Publication number 20140273096
- Publication date Sep 18, 2014
- CSL BEHRING GMBH
- Stefan SCHULTE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY
- Publication number 20140248686
- Publication date Sep 4, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method for Improving the Stability of Purified Factor VIII After Re...
- Publication number 20140249086
- Publication date Sep 4, 2014
- CSL Limited
- Carsten Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATI...
- Publication number 20140161899
- Publication date Jun 12, 2014
- Stefan Schulte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...
- Publication number 20140072561
- Publication date Mar 13, 2014
- CSL BEHRING GMBH
- Thomas Weimer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stefan Schulte

Person

Patents Grantslast 30 patents

Truncated von Willebrand Factor polypeptides for treating hemophilia

Methods for preparing modified von Willebrand Factor

Method for improving the stability of purified Factor VIII after re...

Modified von Willebrand factor having improved half-life

Methods for preparing modified von Willebrand factor

Method for improving the stability of purified Factor VIII after re...

Methods for preparing modified von Willebrand factor

Truncated von Willebrand factor polypeptides for treating hemophilia

Method for improving the stability of purified factor VIII after re...

Sugar compositions for treating hemophilia A and/or Von Willebrand...

Factor XII inhibitors for the administration with medical procedure...

Method for improving the stability of purified factor VIII after re...

Covalent complex of von Willebrand Factor and factor VIII, composit...

Sugar compositions for treating hemophilia A and/or von Willebrand...

Von willebrand factor variants having improved factor VIII binding...

Use of C1-inhibitor for the treatment of secondary edema of the cen...

Method for improving the stability of purified factor VIII after re...

Factor XII inhibitors for the administration with medical procedure...

Coagulation factor X polypeptides with modified activation properties

Factor VIII, von Willebrand factor or complexes thereof with prolon...

Coagulation factor X polypeptides with modified activation properties

Modified vitamin K dependent polypeptides

Modified coagulation factor VIIa with extended half-life

Modified coagulation factors with prolonged in vivo half-life

Factor VIII, von willebrand factor or complexes thereof with prolon...

Therapeutic application of Kazal-type serine protease inhibitors

Proteolytically cleavable fusion proteins with high molar specific...

Concentrate of a factor VIII:C-containing von Willebrand factor and...

Fibrinogen purification

Storage-stable, liquid fibrinogen formulation

Patents Applicationslast 30 patents

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATI...

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA

METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

COVALENT COMPLEX OF VON WILLEBRAND FACTOR AND FACTOR VIII, COMPOSIT...

MODIFIED VON WILLEBRAND FACTOR HAVING IMPROVED HALF-LIFE

COMPOUNDS FOR IMPROVING THE HALF-LIFE OF VON WILLEBRAND FACTOR

Sugar Compositions for Treating Hemophilia A and/or Von Willebrand...

MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE

METHOD FOR IMPROVING THE STABILITY OF PURIFIED FACTOR VIII AFTER RE...

FACTOR XII INHIBITORS FOR THE ADMINISTRATION WITH MEDICAL PROCEDURE...

COMPLEX

PROTEOLYTICALLY CLEAVABLE FUSION PROTEINS WITH HIGH MOLAR SPECIFIC...

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATI...

Sugar Compositions for Treating Hemophilia A and/or Von Willebrand...

USE OF C1-INHIBITOR FOR THE TREATMENT OF SECONDARY EDEMA OF THE CEN...

Von Willebrand Factor Variants Having Improved Factor VIII Binding...

MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE

MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE

THERAPEUTIC POLYPEPTIDES WITH INCREASED IN VIVO RECOVERY

Method for Improving the Stability of Purified Factor VIII After Re...

METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATI...

FACTOR VIII, VON WILLEBRAND FACTOR OR COMPLEXES THEREOF WITH PROLON...